2025 · 2nd Quarter (Apr 1 - June 30)

ASSOCIATION OF ACCESSIBLE MEDICINES (FORMERLY KNOWN AS GPHA)

Filed by FIERCE GOVERNMENT RELATIONS.

Open official filing

Source-reported fields

Filing overview

Type: 2nd Quarter - Report
Posted: Jul 21, 2025
Income: $60,000.00
Expenses: Not reported
Registrant: FIERCE GOVERNMENT RELATIONS
Client: ASSOCIATION OF ACCESSIBLE MEDICINES (FORMERLY KNOWN AS GPHA)
Filing UUID: 3bc614b8-09ab-4fcf-a490-2ada89c460bf
Termination date: Not reported

Literal source text

Lobbying issues and bill citations

PHA · Pharmacy

Supply Chain, Drug Shortages, Tariffs, Patent Thickets, S.1041 - Affordable Prescriptions for Patients Act, S.43 - Skinny Labels - Big Savings Act, S.1302 - A Bill to Provide for Increased Transparency in Generic Drug Applications, S.1954- Biosimilar Red Tape Reduction Act, S.1414 - Expected Access to Biosimilars Act, Access to Biosimilars, Generic Manufacturing Marketplace Issues

Literal federal measure citations: S.1041, S.43, S.1302, S.1954, S.1414

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.